Direct effect of GLP-1 infusion on endogenous glucose production in humans

被引：0
|
作者：
M. Seghieri
E. Rebelos
A. Gastaldelli
B. D. Astiarraga
A. Casolaro
E. Barsotti
A. Pocai
M. Nauck
E. Muscelli
E. Ferrannini
机构：
[1] University of Pisa School of Medicine,Department of Internal Medicine
[2] C.N.R. Institute of Clinical Physiology,undefined
[3] Merck Sharp & Dohme,undefined
[4] Diabeteszentrum Bad Lauterberg,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
Endogenous glucose production; GLP-1; Liver glucose output; Pancreatic clamp;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：156 / 161
页数：5
相关论文
共 50 条
  • [31] Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    D'Souza, Karen M.
    Raravikar, Kalyani
    Liu, James
    Truran, Seth
    Franco, Daniel A.
    Schwartz, Eric A.
    Schwenke, Dawn C.
    D'Alessio, David
    Migrino, Raymond Q.
    Reaven, Peter D.
    DIABETES, 2015, 64 (07) : 2624 - 2635
  • [32] Oxyntomodulin (GLP-1/glucagon) and GLP-1 on Body Weight, Glucose Metabolism and Renal Function
    Pocai, Alessandro
    OBESITY, 2023, 31 : 87 - 87
  • [33] A pilot study examining the effect of GLP1R polymorphisms on insulin secretion in response to glucose and GLP-1 infusion in non-diabetic subjects
    Vella, A.
    Sathananthan, A.
    Micheletto, F.
    Dalla Man, C.
    Toffolo, G.
    Cobelli, C.
    Zinsmeister, A. R.
    Camilleri, M.
    Rizza, R. A.
    DIABETOLOGIA, 2009, 52 : S58 - S58
  • [34] No effect of GLP-1 on human brain glucose delivery during hypoglycaemia
    Lerche, S.
    Brock, B.
    Rungby, J.
    Boetker, H.
    Moeller, N.
    Vang, K.
    Holst, J. J.
    Gjedde, A.
    Schmitz, O.
    DIABETOLOGIA, 2008, 51 : S272 - S273
  • [35] Dilated cardiomyopathy (DCM) is associated with increased myocardial GLP-1 receptors and enhanced myocardial glucose uptake in response to GLP-1 infusion in-conscious dogs
    Poornima, IG
    Nikolaidis, LA
    Doverspike, A
    Zourelias, L
    Machen, L
    Stolarski, C
    Hentosz, T
    Shannon, RP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 174A - 174A
  • [36] Continuous subcutaneous infusion of GLP-1 lowers blood glucose and reduces appetite in NIDDM patients
    Toft-Nielsen, M
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 1998, 41 : A61 - A61
  • [37] GLP-1 Therapy Beyond Glucose Control
    Hausenloy, Derek J.
    Yellon, Derek M.
    CIRCULATION-HEART FAILURE, 2008, 1 (03) : 147 - 149
  • [38] Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells
    Piro, Salvatore
    Mascali, Loriana G.
    Urbano, Francesca
    Filippello, Agnese
    Malaguarnera, Roberta
    Calanna, Salvatore
    Rabuazzo, Agata M.
    Purrello, Francesco
    PLOS ONE, 2014, 9 (02):
  • [39] Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists
    Gasbjerg, Laerke S.
    Bergmann, Natasha C.
    Stensen, Signe
    Christensen, Mikkel B.
    Rosenkilde, Mette M.
    Holst, Jens J.
    Nauck, Michael
    Knop, Filip K.
    PEPTIDES, 2020, 125
  • [40] Is endogenous GLP-1 a major influence on the orbitofrontal cortex?
    May, Aaron A.
    Woods, Stephen C.
    MOLECULAR METABOLISM, 2015, 4 (12): : 977 - 978
12345